Advertisement

Acidic Glycosaminoglycans of SV40-Transformed Werner’s Syndrome Cells

  • Katsumi Murata
  • Mieko Kudo
  • Toshiharu Matsumura
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 190)

Abstract

Patients with Werner’s syndrome (WS) excrete in their urine a relatively high content of hyaluronic acid (HA) among acidic glycosaminoglycan (AGAG) species (Tokunaga et al., 1975, Murata, 1982). Recently a permanent cell line (PSV811) of WS skin cells was established by SV40-transformation (Matsumura et al., in this issue). It is of interest, therefore, to study the release of AGAGs by this cell line. We isolated AGAGs from the culture fluids of PSV811 and of VA13 cells (WI-38 VA13 2RA, i.e., and SV40transformed permanent cell line of human lung cells established by Girardi et al., 1966), and compared them by electrophoresis and desitiometry with respect to the relative contents of AGAGs. We used VA13 cells for comparison because we kept this cell line in our laboratory together with PsV811 and therefore needed to compare them to check the possibility of cell contamination and because we had no more suitable control lines (SV40-transformed permanent line of normal skin fibroblasts) on hand. The relative composition of the AGAGs differed in the two lines. We describe this preliminary difference between the two lines and suggests the possibility of PSV811 carrying a WS trait.

Keywords

Hyaluronic Acid Heparan Sulfate Culture Fluid Dermatan Sulfate Relative Composition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A.J. Girardi, D. Weinstein, and P.S. Moorhead, SV40 transformation of human diploid cells. A parallel study of viral and karyologic parameters, Ann. Med. Exp. Fenn. 44: 242 (1966).PubMedGoogle Scholar
  2. 2.
    T. Matsumura, M. Nagata, R. Konishi, and M. Goto, Studies of SV40-infected Werner’s syndrome fibroblasts, in this issue.Google Scholar
  3. 3.
    K. Murata, Acidic glycosaminoglycans in human platelets and leukocytes: The isolation and enzymatic characterization of chondroitin 4-sulfate, Clin. Chim. Acta. 57: 115 (1974).CrossRefGoogle Scholar
  4. 4.
    K. Murata, Urinary acidic glycosaminoglycans in Werner’s syndrome, Experientia 38: 313 (1982).PubMedCrossRefGoogle Scholar
  5. 5.
    K. Murata, R. Hiwatari, and T. Matsumura, Acidic glycosaminoglycans in the Werner syndorme: Studies on tissue, organ, cell and fluid levels, in this issue.Google Scholar
  6. 6.
    K. Murata, T. Ogura, and T. Okuyama, The acidic glycosaminoglycans in leukocytes: An application of enzymatic methods, Connect. Tissue Res 2: 101 (1974).CrossRefGoogle Scholar
  7. 7.
    N. Seno, K. Anno, K. Kondo, S. Nagase, and S. Saito, Improved method for electrophoretic separation and rapid quantitation of isomeric chondroitin sulfates on cellulose acetate strips, Analyt. Biochem. 37: 197 (1970).Google Scholar
  8. 8.
    M. Tokunaga, T. Futami, E. Wakamatsu, M. Endo, and Z. Yosizawa, Werner’s syndrome as “Hyaluronuria”. Clin. Chim. Acta., 62: 89 (1975).PubMedCrossRefGoogle Scholar
  9. 9.
    E. Wessler, Analytical and preparative separation of acidic glycosaminoglycans by electrophoresis in barium acetate, Analyt. Biochem. 26: 439 (1968).Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Katsumi Murata
    • 1
  • Mieko Kudo
    • 1
  • Toshiharu Matsumura
    • 2
  1. 1.Department of Medicine and Physical Therapy Faculty of MedicineUniversity of TokyoBunkyo-ku, Tokyo 113Japan
  2. 2.Department of Pathobiochemical Cell Research Institute of Medical ScienceUniversity of Tokyo ShirokanedaiMinato-ku Tokyo 108Japan

Personalised recommendations